Medicine and Dentistry
Observational Study
82%
Congestive Heart Failure
81%
Frailty
75%
Community-Acquired Pneumonia
69%
Ascorbic Acid
38%
Nutritional Status
35%
Nutrition
35%
General Medicine
33%
Systematic Review
29%
Hospital Mortality
26%
Cross Sectional Study
26%
Meta-Analysis
22%
Nutrition Assessment
21%
Drug Therapy
19%
Cohort Analysis
19%
Pulmonary Embolism
19%
Lymphocyte
19%
Neutrophil
19%
Randomized Controlled Trial
19%
Charlson Comorbidity Index
18%
Retrospective Study
17%
Adverse Outcome
16%
Logistic Regression Analysis
16%
Heart Failure with Reduced Ejection Fraction
15%
Supplementation
15%
Quality of Life
15%
Prevalence
14%
Ejection Fraction
13%
Seasonal Influenza
13%
COVID-19
12%
Propensity Score Matching
12%
Clinical Significance
11%
Virus Infection
11%
Kidney Function
11%
Health Care Cost
11%
Emergency Department
11%
Retrospective Cohort Study
11%
Comorbidity
10%
Medicine
9%
Cardiology
9%
Influenza A Virus
9%
Cognitive Defect
9%
Health Outcomes
9%
Plummer-Vinson Syndrome
9%
Systolic Blood Pressure
9%
Hospital Inpatient
9%
Malignant Neoplasm
9%
Body Mass Index
9%
Nutritional Intervention
9%
Skeleton
9%
Nursing and Health Professions
Frailty
100%
Hospital Readmission
80%
Clinical Outcome
64%
Hospitalized Older Adults
44%
Congestive Heart Failure
41%
Community Acquired Pneumonia
39%
Nutritional Status
39%
Hospitalization
35%
Quality of Life
31%
Tertiary Care Center
26%
General Practice
22%
Nutrition Assessment
21%
Length of Stay
17%
Elderly Patient
17%
Cross-Sectional Study
16%
Area under the Curve
14%
Propensity Score
13%
Hospital Inpatient
13%
Body Mass
13%
Logistic Regression Analysis
12%
Prevalence
12%
Charlson Comorbidity Index
12%
Health Outcomes
11%
Telehealth
11%
Cohort Analysis
11%
Hospital Mortality
11%
Teaching Hospital
11%
Grip Strength
10%
Drug Therapy
9%
Statin (Protein)
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Quality Adjusted Life Year
9%
Virus Infection
9%
Malignant Neoplasm
9%
Systolic Blood Pressure
9%
Economic Evaluation
9%
Photography
9%
Oseltamivir
9%
Systematic Review
9%
Meta Analysis
9%
Predictive Value
9%
Morbid Obesity
9%
Influenza A
9%
Physical Examination
9%
Heart Failure with Reduced Ejection Fraction
9%
Neutrophil Lymphocyte Ratio
9%
Acute Heart Infarction
9%
Anemia
9%
Hospital Setting
9%
Dietitian
9%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
61%
Frailty
51%
Community Acquired Pneumonia
49%
Congestive Heart Failure
39%
Pharmacotherapy
29%
Cross-Sectional Study
19%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
19%
Retrospective Study
13%
Ascorbic Acid Deficiency
9%
Valsartan/Sacubitril
9%
Ascorbic Acid
9%
Adverse Outcome
9%
Soft Tissue Infection
9%
Seasonal Influenza
9%
Dendrimer
9%
Morbid Obesity
9%
Oseltamivir
9%
Statin (Protein)
9%
Multivitamin
9%
Enoxaparin
9%
Hospital Mortality
8%
Obesity
7%
Comorbidity
7%
Vitamin Deficiency
6%
Blood Clotting Factor 10a
5%
